{"id":"https://openalex.org/A5032756567","orcid":"https://orcid.org/0009-0003-6524-4743","observed_orcids":["https://orcid.org/0009-0003-6524-4743"],"display_name":"Andr\u00e1s Visegr\u00e1dy","raw_author_names":["A. Visegrady","Andr\u00e1s Visegr\u00e1dy","Visegr\u00e1dy, Andr\u00e1s"],"full_name":"Andr\u00e1s Visegr\u00e1dy","works_count":21,"cited_by_count":291,"summary_stats":{"2yr_mean_citedness":1.0,"h_index":9,"i10_index":9},"ids":{"openalex":"https://openalex.org/A5032756567","orcid":"https://orcid.org/0009-0003-6524-4743","observed_orcids":["https://orcid.org/0009-0003-6524-4743"]},"affiliations":[{"institution":{"id":"https://openalex.org/I103163165","ror":"https://ror.org/05g3dte14","display_name":"Florida State University","country_code":"US","type":"education","lineage":["https://openalex.org/I103163165"]},"years":[2006]},{"institution":{"id":"https://openalex.org/I2808169635","ror":"https://ror.org/0033rtn64","display_name":"Gedeon Richter (Hungary)","country_code":"HU","type":"company","lineage":["https://openalex.org/I2808169635"]},"years":[2025,2024,2023,2021,2018,2016,2015,2013,2010,2007]},{"institution":{"id":"https://openalex.org/I79741316","ror":"https://ror.org/037b5pv06","display_name":"University of Pecs","country_code":"HU","type":"education","lineage":["https://openalex.org/I79741316"]},"years":[2001,2000]}],"last_known_institutions":[{"id":"https://openalex.org/I2808169635","ror":"https://ror.org/0033rtn64","display_name":"Gedeon Richter (Hungary)","country_code":"HU","type":"company","lineage":["https://openalex.org/I2808169635"]}],"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","count":10,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","count":5,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","count":4,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11204","display_name":"Ion Channels and Receptors","count":4,"subfield":{"id":"https://openalex.org/subfields/2809","display_name":"Sensory Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","count":4,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","value":3.88e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13415","display_name":"Calcium signaling and nucleotide metabolism","value":3.45e-05,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","value":2.86e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","value":2.44e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11204","display_name":"Ion Channels and Receptors","value":2.17e-05,"subfield":{"id":"https://openalex.org/subfields/2809","display_name":"Sensory Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.858823835849762},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.6194999814033508},{"id":"170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","score":0.6166977882385254},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.5599130988121033},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.4305158257484436}],"counts_by_year":[{"year":1999,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2000,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2001,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2006,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2007,"works_count":2,"oa_works_count":2,"cited_by_count":0},{"year":2010,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2012,"works_count":0,"oa_works_count":0,"cited_by_count":11},{"year":2013,"works_count":1,"oa_works_count":0,"cited_by_count":5},{"year":2014,"works_count":0,"oa_works_count":0,"cited_by_count":11},{"year":2015,"works_count":1,"oa_works_count":1,"cited_by_count":12},{"year":2016,"works_count":1,"oa_works_count":0,"cited_by_count":10},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":8},{"year":2018,"works_count":1,"oa_works_count":0,"cited_by_count":9},{"year":2019,"works_count":0,"oa_works_count":0,"cited_by_count":12},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":4},{"year":2021,"works_count":4,"oa_works_count":2,"cited_by_count":20},{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":24},{"year":2023,"works_count":2,"oa_works_count":1,"cited_by_count":30},{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":29},{"year":2025,"works_count":3,"oa_works_count":2,"cited_by_count":30},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":23}],"display_name_alternatives":["A. Visegrady","Andr\u00e1s Visegr\u00e1dy","Visegr\u00e1dy, Andr\u00e1s"],"block_key":"a visegrady","works_api_url":"https://api.openalex.org/works?filter=author.id:A5032756567","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5032756567","updated_date":"2026-11-12T13:17:38","created_date":"2016-06-24T00:00:00"}